PledPharma Today Announces That the MANAMI Study is Fully Recruited
4/18/2013 11:29:08 AM
Stockholm, 2013-04-18 13:29 CEST (GLOBE NEWSWIRE) -- In the ongoing small investigator initiated clinical phase IIa trial MANAMI, which examines a PLED substance (mangafodipir) in patients with acute myocardial infarction undergoing coronary angioplasty (PCI), all twenty patients are now included. After analyzing the data, we expect to announce results during 2013.
comments powered by